Regulation of the MicroRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis

Journal of Biological Chemistry

Volumn 288, Issue 45, 2013, Pages 32742-32752

  Zhang, Xusen ^a   Zhang, Bailin ^a   Gao, Jidong ^a   Wang, Xiang ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOWN-REGULATION; EXTRACELLULAR MATRICES; HUMAN BREAST CANCER; LYMPH NODE METASTASIS; MICRORNA (MIRNA); NEGATIVE CORRELATION; TRANSCRIPTIONAL REGULATOR; TRANSCRIPTIONAL REPRESSORS;

CELL CULTURE; CELLS; GLYCOPROTEINS; PATHOLOGY; PROTEINS;

RNA;

MESSENGER RNA; MICRORNA 200B; PEPTIDYLPROLYL ISOMERASE PIN1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR PEA3;

3' UNTRANSLATED REGION; ANOIKIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AKT; APOPTOSIS; ERK; ETS FAMILY TRANSCRIPTION FACTOR; MICRORNA;

3' UNTRANSLATED REGIONS; ANOIKIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; ETS-DOMAIN PROTEIN ELK-1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; PEPTIDYLPROLYL ISOMERASE; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 84887480653     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.478016     Document Type: Article

References (61)

1. Nguyen, D. X., Bos, P. D., and Massagué, J. (2009) Metastasis. From dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284
2. Bartel, D. P. (2009) MicroRNAs. Target recognition and regulatory functions. Cell 136, 215-233
3. Shukla, G. C., Singh, J., and Barik, S. (2011) MicroRNAs. Processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol. 3, 83-92
4. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., and Calin, G. A. (2009) MicroRNAs. The micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302
5. Lujambio, A., and Lowe, S. W. (2012) The microcosmos of cancer. Nature 482, 347-355
6. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., and Brabletz, T. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589
7. Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., and Goodall, G. J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601
8. Park, S. M., Gaur, A. B., Lengyel, E., and Peter, M. E. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907
9. Korpal, M., Lee, E. S., Hu, G., and Kang, Y. (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914
10. Howe, E. N., Cochrane, D. R., and Richer, J. K. (2011) Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13, R45
11. Wulf, G., Garg, P., Liou, Y. C., Iglehart, D., and Lu, K. P. (2004) Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 23, 3397-3407
12. Fukuchi, M., Fukai, Y., Kimura, H., Sohda, M., Miyazaki, T., Nakajima, M., Masuda, N., Tsukada, K., Kato, H., and Kuwano, H. (2006) Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int. J. Oncol. 29, 329-334
13. Lu, K. P., Suizu, F., Zhou, X. Z., Finn, G., Lam, P., and Wulf, G. (2006) Targeting carcinogenesis. A role for the prolyl isomerase Pin1? Mol. Carcinog. 45, 397-402
14. Pang, R., Lee, T. K., Poon, R. T., Fan, S. T., Wong, K. B., Kwong, Y. L., and Tse, E. (2007) Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132, 1088-1103
15. Pang, R. W., Lee, T. K., Man, K., Poon, R. T., Fan, S. T., Kwong, Y. L., and Tse, E. (2006) PIN1 expression contributes to hepatic carcinogenesis. J. Pathol. 210, 19-25
16. Tan, X., Zhou, F., Wan, J., Hang, J., Chen, Z., Li, B., Zhang, C., Shao, K., Jiang, P., Shi, S., Feng, X., Lv, N., Wang, Z., Ling, Y., Zhao, X., Ding, D., Sun, J., Xiong, M., and He, J. (2010) Pin1 expression contributes to lung cancer. Prognosis and carcinogenesis. Cancer Biol. Ther. 9, 111-119
17. Girardini, J. E., Napoli, M., Piazza, S., Rustighi, A., Marotta, C., Radaelli, E., Capaci, V., Jordan, L., Quinlan, P., Thompson, A., Mano, M., Rosato, A., Crook, T., Scanziani, E., Means, A. R., Lozano, G., Schneider, C., and Del Sal, G. (2011) A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20, 79-91
18. Han, C. Y., Hien, T. T., Lim, S. C., and Kang, K. W. (2011) Role of Pin1 in UVA-induced cell proliferation and malignant transformation in epidermal cells. Biochem. Biophys. Res. Commun. 410, 68-74
19. Liao, Y., Wei, Y., Zhou, X., Yang, J. Y., Dai, C., Chen, Y. J., Agarwal, N. K., Sarbassov, D., Shi, D., Yu, D., and Hung, M. C. (2009) Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 28, 2436-2445
20. Liao, Y., and Hung, M. C. (2010) Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2, 19-42
21. Uchida, T., Furumai, K., Fukuda, T., Akiyama, H., Takezawa, M., Asano, T., Fujimori, F., and Uchida, C. (2012) Prolyl isomerase Pin1 regulates mouse embryonic fibroblast differentiation into adipose cells. PLoS ONE 7, e31823
22. Meadows, S. M., Myers, C. T., and Krieg, P. A. (2011) Regulation of endothelial cell development by ETS transcription factors. Semin. Cell Dev. Biol. 22, 976-984
23. Turner, D. P., and Watson, D. K. (2008) ETS transcription factors. Oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev. Anticancer Ther. 8, 33-42
24. Gutierrez-Hartmann, A., Duval, D. L., and Bradford, A. P. (2007) ETS transcription factors in endocrine systems. Trends Endocrinol. Metab. 18, 150-158
25. de Launoit, Y., Baert, J. L., Chotteau-Lelievre, A., Monte, D., Coutte, L., Mauen, S., Firlej, V., Degerny, C., and Verreman, K. (2006) The Ets transcription factors of the PEA3 group. Transcriptional regulators in metastasis. Biochim. Biophys. Acta 1766, 79-87
26. Seth, A., and Watson, D. K. (2005) ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41, 2462-2478
27. Kim, J. B., Yu, J. H., Ko, E., Lee, K. W., Song, A. K., Park, S. Y., Shin, I., Han, W., and Noh, D. Y. (2010) The alkaloid berberine inhibits the growth of anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 17, 436-440
28. Wang, Z., Yang, J., Fisher, T., Xiao, H., Jiang, Y., and Yang, C. (2012) Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ. Health Perspect. 120, 92-97
29. Ma, B., Sen, T., Asnaghi, L., Valapala, M., Yang, F., Hose, S., McLeod, D. S., Lu, Y., Eberhart, C., Zigler, J. S., Jr., and Sinha, D. (2011) βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/ AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis. Cell Death Dis. 2, e217
30. Ahn, S. M., Cha, J. Y., Kim, J., Kim, D., Trang, H. T., Kim, Y. M., Cho, Y. H., Park, D., and Hong, S. (2012) Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene 31, 3051-3059
31. Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., and Goodall, G. J. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res. 68, 7846-7854
32. Guo, B., and Sharrocks, A. D. (2009) Extracellular signal-regulated kinase mitogen-activated protein kinase signaling initiates a dynamic interplay between SUMOylation and ubiquitination to regulate the activity of the transcriptional activator PEA3. Mol. Cell. Biol. 29, 3204-3218
33. Oh, Y. T., Liu, X., Yue, P., Kang, S., Chen, J., Taunton, J., Khuri, F. R., and Sun, S. Y. (2010) ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1. J. Biol. Chem. 285, 41310-41319
34. Cohen-Armon, M. (2007) PARP-1 activation in the ERK signaling pathway. Trends Pharmacol. Sci. 28, 556-560
35. Ding, Q., Huo, L., Yang, J. Y., Xia, W., Wei, Y., Liao, Y., Chang, C. J., Yang, Y., Lai, C. C., Lee, D. F., Yen, C. J., Chen, Y. J., Hsu, J. M., Kuo, H. P., Lin, C. Y., Tsai, F. J., Li, L. Y., Tsai, C. H., and Hung, M. C. (2008) Downregulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res. 68, 6109-6117
36. Monje, P., Hernández-Losa, J., Lyons, R. J., Castellone, M. D., and Gutkind, J. S. (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280, 35081-35084
37. Al-Ayoubi, A., Tarcsafalvi, A., Zheng, H., Sakati, W., and Eblen, S. T. (2008) ERK activation and nuclear signaling induced by the loss of cell/ matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells. J. Cell. Biochem. 105, 875-884
38. Zhang, L., Volinia, S., Bonome, T., Calin, G. A., Greshock, J., Yang, N., Liu, C. G., Giannakakis, A., Alexiou, P., Hasegawa, K., Johnstone, C. N., Megraw, M. S., Adams, S., Lassus, H., Huang, J., Kaur, S., Liang, S., Sethupathy, P., Leminen, A., Simossis, V. A., Sandaltzopoulos, R., Naomoto, Y., Katsaros, D., Gimotty, P. A., DeMichele, A., Huang, Q., Bützow, R., Rustgi, A. K., Weber, B. L., Birrer, M. J., Hatzigeorgiou, A. G., Croce, C. M., and Coukos, G. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 7004-7009
39. Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L.T., Hijiya, N., Uchida, T., Sato, F., Mimata, H., Seto, M., and Moriyama, M. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma. Significant down-regulation of miR-141 and miR-200c. J. Pathol. 216, 418-427
40. Nam, E. J., Yoon, H., Kim, S. W., Kim, H., Kim, Y. T., Kim, J. H., Kim, J. W., and Kim, S. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 14, 2690-2695
41. Bockmeyer, C. L., Christgen, M., Müller, M., Fischer, S., Ahrens, P., Länger, F., Kreipe, H., and Lehmann, U. (2011) MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res. Treat. 130, 735-745
42. Aydoǧdu, E., Katchy, A., Tsouko, E., Lin, C. Y., Haldosén, L. A., Helguero, L., and Williams, C. (2012) MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 33, 1502-1511
43. Guttilla, I. K., Adams, B. D., and White, B. A. (2012) ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol. Metab. 23, 73-82
44. Castañeda, C. A., Agullo-Ortuño, M. T., Fresno Vara, J. A., Cortes-Funes, H., Gomez, H. L., and Ciruelos, E. (2011) Implication of miRNA in the diagnosis and treatment of breast cancer. Expert Rev. Anticancer Ther. 11, 1265-1275
45. Smit, M. A., and Peeper, D. S. (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30, 3735-3744
46. Kamarajugadda, S., Stemboroski, L., Cai, Q., Simpson, N. E., Nayak, S., Tan, M., and Lu, J. (2012) Glucose oxidation modulates anoikis and tumor metastasis. Mol. Cell. Biol. 32, 1893-1907
47. Frisch, S. M., and Ruoslahti, E. (1997) Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701-706
48. Frisch, S. M., and Screaton, R. A. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562
49. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70
50. Chan, Y. C., Roy, S., Khanna, S., and Sen, C. K. (2012) Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler. Thromb. Vasc. Biol. 32, 1372-1382
51. McArthur, K., Feng, B., Wu, Y., Chen, S., and Chakrabarti, S. (2011) MicroRNA- 200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 60, 1314-1323
52. Choi, Y. C., Yoon, S., Jeong, Y., Yoon, J., and Baek, K. (2011) Regulation of vascular endothelial growth factor signaling by miR-200b. Mol. Cells 32, 77-82
53. Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., Haley, B., Morrison, L., Fleming, T. P., Herlyn, D., Terstappen, L. W., Fehm, T., Tucker, T. F., Lane, N., Wang, J., and Uhr, J. W. (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152-8162
54. Mathiesen, R. R., Fjelldal, R., Liestøl, K., Due, E. U., Geigl, J. B., Riethdorf, S., Borgen, E., Rye, I. H., Schneider, I. J., Obenauf, A. C., Mauermann, O., Nilsen, G., Christian Lingjaerde, O., Børresen-Dale, A. L., Pantel, K., Speicher, M. R., Naume, B., and Baumbusch, L. O. (2012) High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. Int. J. Cancer 131, E405-E415
55. Villalonga, P., Guasch, R. M., Riento, K., and Ridley, A. J. (2004) RhoE inhibits cell cycle progression and Ras-induced transformation. Mol. Cell. Biol. 24, 7829-7840
56. Xia, W., Li, J., Chen, L., Huang, B., Li, S., Yang, G., Ding, H., Wang, F., Liu, N., Zhao, Q., Fang, T., Song, T., Wang, T., and Shao, N. (2010) MicroRNA- 200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem. 344, 261-266
57. Hyun, S., Lee, J. H., Jin, H., Nam, J., Namkoong, B., Lee, G., Chung, J., and Kim, V. N. (2009) Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 139, 1096-1108
58. Peter, M. E. (2009) Let-7 and miR-200 microRNAs. Guardians against pluripotency and cancer progression. Cell Cycle 8, 843-852
59. Sieuwerts, A. M., Mostert, B., Bolt-de Vries, J., Peeters, D., de Jongh, F. E., Stouthard, J. M., Dirix, L. Y., van Dam, P. A., Van Galen, A., de Weerd, V., Kraan, J., van der Spoel, P., Ramírez-Moreno, R., van Deurzen, C. H., Smid, M., Yu, J. X., Jiang, J., Wang, Y., Gratama, J. W., Sleijfer, S., Foekens, J. A., and Martens, J. W. (2011) mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 17, 3600-3618
60. Xu, K., Klenk, C., Liu, B., Keiner, B., Cheng, J., Zheng, B. J., Li, L., Han, Q., Wang, C., Li, T., Chen, Z., Shu, Y., Liu, J., Klenk, H. D., and Sun, B. (2011) Modification of nonstructural protein 1 of influenza A virus by SUMO1. J. Virol. 85, 1086-1098
61. Tang, F., Hajkova, P., Barton, S. C., Lao, K., and Surani, M. A. (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 34, e9